Patents Assigned to Univeristy of Florida Research Foundation, Inc.
-
Patent number: 8652817Abstract: Disclosed are recombinant host cells suitable for degrading an oligosaccharide that have been optimized for growth and production of high yields of ethanol, and methods of making and using these cells. The invention further provides minimal media comprising urea-like compounds for economical production of ethanol by recombinant microorganisms. Recombinant host cells in accordance with the invention are modified by gene mutation to eliminate genes responsible for the production of unwanted products other than ethanol, thereby increasing the yield of ethanol produced from the oligosaccharides, relative to unmutated parent strains. The new and improved strains of recombinant bacteria are capable of superior ethanol productivity and yield when grown under conditions suitable for fermentation in minimal growth media containing inexpensive reagents. Systems optimized for ethanol production combine a selected optimized minimal medium with a recombinant host cell optimized for use in the selected medium.Type: GrantFiled: June 30, 2006Date of Patent: February 18, 2014Assignee: Univeristy of Florida Research Foundation, Inc.Inventors: Brent E. Wood, Lonnie O. Ingram, Lorraine P. Yomano, Sean W. York
-
Publication number: 20120098599Abstract: An enhancement mode (E-mode) HEMT is provided that can be used for analog and digital applications. In a specific embodiment, the HEMT can be an AlN/GaN HEMT. The subject E-mode device can be applied to high power, high voltage, high temperature applications, including but not limited to telecommunications, switches, hybrid electric vehicles, power flow control and remote sensing. According to an embodiment of the present invention, E-mode devices can be fabricated by performing an oxygen plasma treatment with respect to the gate area of the HEMT. The oxygen plasma treatment can be, for example, an O2 plasma treatment. In addition, the threshold voltage of the E-mode HEMT can be controlled by adjusting the oxygen plasma exposure time. By using a masking layer protecting regions for depletion mode (D-mode) devices, D-mode and E-mode devices can be fabricated on a same chip.Type: ApplicationFiled: June 29, 2010Publication date: April 26, 2012Applicant: Univeristy of Florida Research Foundation Inc.Inventors: Chih-Yang Chang, Fan Ren, Stephen John Pearton
-
Patent number: 8099152Abstract: A method of formulating a patient-specific plan for a diagnostic or therapeutic procedure performed upon a patient is provided. The method includes obtaining a standard plan based upon a scan of an anatomy of a standard anatomic specimen, the scan defining a standard scan. The method also includes scanning the patient to obtain a patient-specific scan of an anatomy of the patient. Additionally, the method includes morphing the standard scan to the anatomy of the patient by mapping the standard scan to the patient-specific scan. The method further includes determining the patient-specific plan by modifying the standard plan based upon the mapping.Type: GrantFiled: February 17, 2006Date of Patent: January 17, 2012Assignee: Univeristy of Florida Research Foundation, Inc.Inventors: Frank J. Bova, William A. Friedman
-
Publication number: 20100129815Abstract: The subject invention pertains to the association of a MLCK homologue with cardiac tissue and methods of identifying candidate compounds that can modulate the activity of this MLCK homologue and the expression of MLCK gene product. Additionally, methods of treating heart failure are also provided by the subject invention.Type: ApplicationFiled: April 14, 2008Publication date: May 27, 2010Applicant: UNIVERISTY OF FLORIDA RESEARCH FOUNDATION INC.Inventor: Hideko Kasahara
-
Publication number: 20090208936Abstract: We report the real-time monitoring of protein-protein interactions without labeling either of the two interacting proteins, posing minimum effects on the binding properties of the proteins. In particular, the methods provide protein/aptamer complexes to probe the interactions in a competitive assay where the binding of an aptamer to its target protein is altered by a second protein that interacts with the target protein. Two signal transduction strategies, fluorescence resonance energy transfer (FRET) and fluorescence anisotropy, are described.Type: ApplicationFiled: January 4, 2006Publication date: August 20, 2009Applicant: Univeristy of Florida Research Foundations Inc.Inventors: Weihong Tan, Zehui Cao
-
Patent number: 7273709Abstract: A gene encoding a 29 kilodalton protein found on the surface of merozoite stage S. neurona has been cloned and sequenced. The protein encoded by this gene, termed SnSAG-1, is an immunodominant antigen recognized on protein blots. Methods for using nucleic acids and polypeptides relating to SnSAG-1 in diagnostic tests and vaccine development are disclosed.Type: GrantFiled: August 10, 2004Date of Patent: September 25, 2007Assignee: Univeristy of Florida Research Foundation, Inc.Inventors: John B. Dame, Siobhan P. Ellison, Charles A. Yowell
-
Publication number: 20050250192Abstract: The subject invention relates to newly isolated organisms from nature that produce L(+)-lactic acid high yield from hexose and pentose sugars found in biomass. Organisms and processes or methods for the production of lactic acid and other industrially important chemicals from cellulose and hemicellulose are also provided.Type: ApplicationFiled: March 4, 2004Publication date: November 10, 2005Applicant: Univeristy of Florida Research Foundation, Inc.Inventors: Keelnatham Shanmugam, Lonnie Ingram, Milind Patel, Mark Ou, Roberta Harbrucker